Suppr超能文献

器官功能障碍作为定义脓毒症的新标准。

Organ dysfunction as a new standard for defining sepsis.

作者信息

Fujishima Seitaro

机构信息

Center for General Medicine Education, Keio University School of Medicine, Tokyo, Japan.

出版信息

Inflamm Regen. 2016 Nov 15;36:24. doi: 10.1186/s41232-016-0029-y. eCollection 2016.

Abstract

Despite advances in intensive care and the widespread use of standardized care included in the Surviving Sepsis Campaign Guidelines, sepsis remains a leading cause of death, and the prevalence of sepsis increases concurrent with the aging process. The diagnosis of sepsis was originally based on the evidence of persistent bacteremia (septicemia) but was modified in 1992 to incorporate systemic inflammatory response syndrome (SIRS). Since then, SIRS has become the gold standard for the diagnosis of sepsis. In 2016, the Society of Critical Care Medicine and the European Society of Intensive Care Medicine published a new clinical definition of sepsis that is called Sepsis-3. In contrast to previous definitions, Sepsis-3 is based on organ dysfunctions and uses a sequential organ failure (SOFA) score as an index. Thus, patients diagnosed with respect to Sepsis-3 will inevitably represent a different population than those previously diagnosed. We assume that this drastic change in clinical definition will affect not only clinical practice but also the viewpoint and focus of basic research. This review intends to summarize the pathophysiology of sepsis and organ dysfunction and discusses potential directions for future research.

摘要

尽管重症监护取得了进展,且《拯救脓毒症运动指南》中包含的标准化治疗得到广泛应用,但脓毒症仍是主要的死亡原因,并且脓毒症的患病率随着衰老过程而增加。脓毒症的诊断最初基于持续性菌血症(败血症)的证据,但在1992年进行了修改,纳入了全身炎症反应综合征(SIRS)。从那时起,SIRS已成为脓毒症诊断的金标准。2016年,危重病医学会和欧洲重症监护医学会发表了一种新的脓毒症临床定义,称为Sepsis-3。与先前的定义不同,Sepsis-3基于器官功能障碍,并使用序贯器官衰竭评估(SOFA)评分作为指标。因此,根据Sepsis-3诊断出的患者必然与先前诊断出的患者代表不同的人群。我们认为,临床定义的这种巨大变化不仅会影响临床实践,还会影响基础研究的观点和重点。本综述旨在总结脓毒症和器官功能障碍的病理生理学,并讨论未来研究的潜在方向。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验